A Survival Analysis of Hypopharyngeal Cancer Patients: A Hospital-Cancer registry Based Study

被引:0
作者
Manigreeva Krishnatreya
Amal Chandra Kataki
Jagannath Dev Sharma
Nizara Baishya
Tashnin Rahman
Mouchumee Bhattcharyya
Ashok Kumar Das
Manoj Kalita
机构
[1] Dr B. Borooah Cancer Institute,Department of Cancer Epidemiology and Biostatistics
[2] Dr B. Borooah Cancer Institute,Patterns of Care and Survival Project
[3] Dr B. Borooah Cancer Institute,Department of Pathology
[4] Dr B. Borooah Cancer Institute,Hospital Based Cancer Registry
[5] Dr B. Borooah Cancer Institute,National Cancer Registry Programme
[6] Dr B. Borooah Cancer Institute,Department of Head and Neck Oncology
[7] Dr B. Borooah Cancer Institute,Department of Radiation Oncology
来源
Indian Journal of Otolaryngology and Head & Neck Surgery | 2019年 / 71卷
关键词
Chemotherapy; Hypopharynx; Radiotherapy; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
To study the survival in patients affected with hypopharyngeal cancer among treatment groups and different stages. Data of hypopharyngeal cancer patients diagnosed from 1st January 2010 to 31st December 2010 was used in the present study. The cases were analyzed for gender, age group distribution, sub-sites at presentation, stage at diagnosis and the type of treatments. Survival from the date of first diagnosis was estimated and hazard ratios were calculated. Survival probability and hazards ratios (HR) were calculated by Kaplan–Meier method and Cox-proportional regression analysis respectively. Censoring of patient who survived longer than 5 years was done. Active follow-up was done for the survival analysis. The study cohort included 217 patients and treatment compliance was observed in 46.9% of cases. The median age at diagnosis was 57 years (range 24–90), 86.2% of cases were locally advanced cases (stage III and IV), pyriform sinus was major sub-site (96%), radiotherapy was main treatment modality alone in 84.8% of cases, median survival was 31 months and 5-year overall survival was 36.9%, and HR for stage IV was 1.9 (P = 0.03, 95% CI − 1.04 to 3.7). In developing setting of North East India, radiotherapy was the main modality of treatment for hypopharyngeal cancer patients, and understanding the clinical parameters and survival of this group of cancers is crucial for its control.
引用
收藏
页码:798 / 804
页数:6
相关论文
共 154 条
[21]  
Andrae M(2007)Hypopharyngeal cancer Top Magn Reson Imaging 18 243-1741
[22]  
Chen YS(2014)Prognostic significance of the number of positive lymph nodes, number of involved regions and metastatic lymph node ratio in hypopharyngeal cancer Zhonghua Zhong Liu Za Zhi 36 783-1754
[23]  
Makoski HB(2015)Prognostic factor of severe complications in patients with hypopharyngeal cancer with primary concurrent chemoradiotherapy Anticancer Res 35 1735-1237
[24]  
Schröder M(2016)Survival in head and neck cancers- results of a multi-institution study Asian Pac J Cancer Prev 17 1745-792
[25]  
Sesterhenn K(2017)Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis Lancet Oncol 18 1221-684
[26]  
Iseli TA(2017)Adjuvant chemoradiation after surgical resection in elderly patients with high-risk squamous cell carcinoma of the head and neck: a National Cancer database analysis Int J Radiat Oncol Biol Phys 98 784-189
[27]  
Agar NJ(2017)Utilization and Survival of Postoperative Radiation or Chemoradiation for pT1-2N1M0 Head and Neck Cancer Otolaryngology–Head and Neck Surgery 158 677-640
[28]  
Dunemann C(2018)Trends in treatment, incidence and survival of hypopharynx cancer: a 20-year population-based study in the Netherlands Eur Arch Otorhinolaryngol 275 181-undefined
[29]  
Layons BM(2015)Primary surgery vs chemoradiation treatment of advanced-stage hypopharyngeal squamous cell carcinoma JAMA Otolaryngol Head Neck Surg 141 636-undefined
[30]  
Milisavljevic D(undefined)undefined undefined undefined undefined-undefined